世界の副甲状腺ホルモンアナログ市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC6818)
◆英語タイトル:Global Parathyroid Hormone Analog Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20DC6818
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、副甲状腺ホルモンアナログの世界市場を広く調査・分析し、今後の市場展望をまとめております。副甲状腺ホルモンアナログの種類別市場規模(アバロパラチド、テリパラチド、ヒト副甲状腺ホルモン組換え体)、用途別市場規模(病院、診療所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Cell Genesys Inc、Natpara、Abbott Laboratories、Eli Lilly、Merck、Paladin Labs Inc、Sanofi SA、GlaxoSmithKline Plc、OSI Pharmaceuticals、ALZA Corporation、
・地域別グローバル市場分析 2015年-2020年
・副甲状腺ホルモンアナログの北米市場(アメリカ、カナダ、メキシコ)
・副甲状腺ホルモンアナログのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・副甲状腺ホルモンアナログのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・副甲状腺ホルモンアナログの南米市場(ブラジル、アルゼンチン)
・副甲状腺ホルモンアナログの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アバロパラチド、テリパラチド、ヒト副甲状腺ホルモン組換え体
・用途別分析:病院、診療所、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Parathyroid Hormone Analog market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Parathyroid Hormone Analog market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Parathyroid Hormone Analog market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Parathyroid Hormone Analog market has been segmented into
Abaloparatide
Teriparatide
Human Parathyroid Hormone Recombinant

By Application, Parathyroid Hormone Analog has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parathyroid Hormone Analog market presented in the report. This section sheds light on the sales growth of different regional and country-level Parathyroid Hormone Analog markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parathyroid Hormone Analog market.

The report offers in-depth assessment of the growth and other aspects of the Parathyroid Hormone Analog market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Parathyroid Hormone Analog Market Share Analysis
Parathyroid Hormone Analog competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parathyroid Hormone Analog sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parathyroid Hormone Analog sales, revenue and market share for each player covered in this report.

The major players covered in Parathyroid Hormone Analog are:
Pfizer
Cell Genesys Inc
Natpara
Abbott Laboratories
Eli Lilly
Merck
Paladin Labs Inc
Sanofi SA
GlaxoSmithKline Plc
OSI Pharmaceuticals
ALZA Corporation

Among other players domestic and global, Parathyroid Hormone Analog market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parathyroid Hormone Analog product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parathyroid Hormone Analog, with price, sales, revenue and global market share of Parathyroid Hormone Analog in 2018 and 2019.
Chapter 3, the Parathyroid Hormone Analog competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parathyroid Hormone Analog breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Parathyroid Hormone Analog market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Parathyroid Hormone Analog sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Parathyroid Hormone Analog Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parathyroid Hormone Analog Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Abaloparatide
1.2.3 Teriparatide
1.2.4 Human Parathyroid Hormone Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Parathyroid Hormone Analog Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Parathyroid Hormone Analog Market
1.4.1 Global Parathyroid Hormone Analog Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cell Genesys Inc
2.2.1 Cell Genesys Inc Details
2.2.2 Cell Genesys Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cell Genesys Inc SWOT Analysis
2.2.4 Cell Genesys Inc Product and Services
2.2.5 Cell Genesys Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Natpara
2.3.1 Natpara Details
2.3.2 Natpara Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Natpara SWOT Analysis
2.3.4 Natpara Product and Services
2.3.5 Natpara Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Paladin Labs Inc
2.7.1 Paladin Labs Inc Details
2.7.2 Paladin Labs Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Paladin Labs Inc SWOT Analysis
2.7.4 Paladin Labs Inc Product and Services
2.7.5 Paladin Labs Inc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi SA
2.8.1 Sanofi SA Details
2.8.2 Sanofi SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SA SWOT Analysis
2.8.4 Sanofi SA Product and Services
2.8.5 Sanofi SA Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc
2.9.1 GlaxoSmithKline Plc Details
2.9.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Plc SWOT Analysis
2.9.4 GlaxoSmithKline Plc Product and Services
2.9.5 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 OSI Pharmaceuticals
2.10.1 OSI Pharmaceuticals Details
2.10.2 OSI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 OSI Pharmaceuticals SWOT Analysis
2.10.4 OSI Pharmaceuticals Product and Services
2.10.5 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ALZA Corporation
2.11.1 ALZA Corporation Details
2.11.2 ALZA Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ALZA Corporation SWOT Analysis
2.11.4 ALZA Corporation Product and Services
2.11.5 ALZA Corporation Parathyroid Hormone Analog Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parathyroid Hormone Analog Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parathyroid Hormone Analog Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.3.2 Top 6 Parathyroid Hormone Analog Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
4.1.1 Global Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
4.2 North America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.3 Europe Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.5 South America Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
5.1.1 North America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
5.1.2 North America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
5.2 United States Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.3 Canada Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
5.4 Mexico Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
6.1.1 Europe Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
6.2 Germany Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.3 UK Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.4 France Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.5 Russia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
6.6 Italy Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parathyroid Hormone Analog Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parathyroid Hormone Analog Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parathyroid Hormone Analog Revenue and Market Share by Regions (2015-2020)
7.2 China Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.3 Japan Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.4 Korea Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.5 India Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
7.7 Australia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
8.1.1 South America Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
8.1.2 South America Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
8.3 Argentina Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parathyroid Hormone Analog Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parathyroid Hormone Analog Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parathyroid Hormone Analog Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.3 Turkey Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.4 Egypt Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
9.5 South Africa Parathyroid Hormone Analog Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parathyroid Hormone Analog Sales and Market Share by Type (2015-2020)
10.2 Global Parathyroid Hormone Analog Revenue and Market Share by Type (2015-2020)
10.3 Global Parathyroid Hormone Analog Price by Type (2015-2020)
11 Global Parathyroid Hormone Analog Market Segment by Application
11.1 Global Parathyroid Hormone Analog Sales Market Share by Application (2015-2020)
11.2 Global Parathyroid Hormone Analog Revenue Market Share by Application (2015-2020)
11.3 Global Parathyroid Hormone Analog Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parathyroid Hormone Analog Sales, Revenue and Growth Rate (2021-2025)
12.2 Parathyroid Hormone Analog Market Forecast by Regions (2021-2025)
12.2.1 North America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.2 Europe Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.4 South America Parathyroid Hormone Analog Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parathyroid Hormone Analog Market Forecast (2021-2025)
12.3 Parathyroid Hormone Analog Market Forecast by Type (2021-2025)
12.3.1 Global Parathyroid Hormone Analog Sales Forecast by Type (2021-2025)
12.3.2 Global Parathyroid Hormone Analog Market Share Forecast by Type (2021-2025)
12.4 Parathyroid Hormone Analog Market Forecast by Application (2021-2025)
12.4.1 Global Parathyroid Hormone Analog Sales Forecast by Application (2021-2025)
12.4.2 Global Parathyroid Hormone Analog Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Pfizer、Cell Genesys Inc、Natpara、Abbott Laboratories、Eli Lilly、Merck、Paladin Labs Inc、Sanofi SA、GlaxoSmithKline Plc、OSI Pharmaceuticals、ALZA Corporation、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の副甲状腺ホルモンアナログ市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Parathyroid Hormone Analog Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。